 |
TOKYO and WOODCLIFF LAKE, N.J., July 2 /PRNewswire/ — Eisai Co., Ltd. and Eisai Corporation of North America are currently focusing on three clinical development programs for the company's major product Aricept to further contribute to patients with Alzheimer's disease.
More: continued here
Yahoo! News Jul 2 2009 1:41PM GMT
More: continued here
Street Insider Jul 2 2009 12:20PM GMT
More: continued here
CNN Money Jul 2 2009 12:55PM GMT
More: continued here
Reuters Jul 2 2009 1:35PM GMT
More: continued here
ThirdSector Jul 2 2009 12:56PM GMT
More: continued here
US drug maker Johnson & Johnson is to take an 18.4% stake in Dublin-listed Elan as part of a deal under which it will take over some of Elan's research into the treatment of Alzheimer's disease.
More: continued here
FOXBusiness.com Jul 2 2009 12:34PM GMT
More: continued here
Financial Post Jul 2 2009 2:21PM GMT
More: continued here
Reuters Jul 2 2009 1:04PM GMT
More: continued here
 |
Powered by FireStats